Psoriasis Treatment Ustekinumab Reduces Vascular Inflammation
Ustekinumab improves psoriasis and reduces vascular inflammation among patients with moderate-to-severe psoriasis.
AAD 2018
Oral Fluralaner a Low-Cost, Effective Scabies Treatment
Results comparing treatments for scabies were presented at the 2018 American Academy of Dermatology Annual Meeting.
Atopic Dermatitis Significantly Improved With Upadacitinib 30 mg
The efficacy and generally safe profile of upadacitinib supports advancing to a phase 3 trial.
Risankizumab Superior to Ustekinumab for Severe Chronic Plaque Psoriasis
Combined results from the UltIMMa-1 and UltIMMa-2 trials were presented at the 2018 American Academy of Dermatology Annual Meeting in San Diego.
Genetic Risk Stratification Test May Guide Melanoma Management
Identifying risk of metastasis in patients with melanoma may help clinicians determine initial workup, referral patterns, and follow-up intervals.
Novel JAK/SYK Inhibitor Safe, Effective for Atopic Dermatitis
Data from a preliminary placebo-controlled trial on ASN002 were presented at the 2018 American Academy of Dermatology Annual Meeting.
Want to read more?
Please login or register first to view this content.
Next post in AAD 2018
